CompletedPHASE1, PHASE2NCT02381366

Safety and Efficacy of PNEUMOSTEM® in Premature Infants at High Risk for Bronchopulmonary Dysplasia (BPD) - a US Study

Studying Bronchopulmonary dysplasia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Medipost, Inc.
Principal Investigator
Steven Powell, MD, MD
Rush University Medical Center
Intervention
Human Umbilical Cord Blood Derived-Mesenchymal Stem Cells(biological)
Enrollment
12 enrolled
Eligibility
All sexes
Timeline
20152018

Study locations (1)

Collaborators

Medipost Co Ltd.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02381366 on ClinicalTrials.gov

Other trials for Bronchopulmonary dysplasia

Additional recruiting or active studies for the same condition.

See all trials for Bronchopulmonary dysplasia

← Back to all trials